Patents by Inventor David C. Anderson

David C. Anderson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12062464
    Abstract: Collimators and other components for use in neutron scattering experiments or to provide neutron shielding in nuclear reactors or accelerator based neutron sources are produced by additive manufacturing from neutron absorbing material, such as boron carbide (B4C) or isotopically enriched boron carbide (10B).
    Type: Grant
    Filed: August 1, 2022
    Date of Patent: August 13, 2024
    Assignee: UT-Battelle, LLC
    Inventors: David C. Anderson, Anibal J. Ramirez-Cuesta, Matthew B. Stone, Amelia M. Elliott, Derek H. Siddel
  • Patent number: 11898226
    Abstract: A method for additive manufacturing of a composite object containing a bonded network of boron carbide particles and aluminum occupying spaces between boron carbide particles, the method comprising: (i) producing a porous preform constructed of boron carbide by an additive manufacturing process in which particles of boron carbide are bonded together; and (ii) infiltrating molten aluminum, at a temperature of 1000-1400° C., into pores of said porous preform to produce said composite object constructed of boron carbide particles within an aluminum matrix, wherein the boron carbide is present in the composite object in an amount of 30-70 wt. %. The resulting composite material is also herein described.
    Type: Grant
    Filed: February 25, 2020
    Date of Patent: February 13, 2024
    Assignee: UT-Battelle, LLC
    Inventors: Corson L. Cramer, James O. Kiggans, Jr., Amelia M. Elliott, David C. Anderson
  • Publication number: 20230041882
    Abstract: Collimators and other components for use in neutron scattering experiments or to provide neutron shielding in nuclear reactors or accelerator based neutron sources are produced by additive manufacturing from neutron absorbing material, such as boron carbide (B4C) or isotopically enriched boron carbide (10B).
    Type: Application
    Filed: August 1, 2022
    Publication date: February 9, 2023
    Inventors: David C. Anderson, Anibal J. Ramirez-Cuesta, Matthew B. Stone, Amelia M. Elliott, Derek H. Siddel
  • Patent number: 11538597
    Abstract: Collimators and other components for use in neutron scattering experiments or to provide neutron shielding in nuclear reactors or accelerator based neutron sources are produced by additive manufacturing from multiple different types of material, such as boron carbide (B4C), steel, isotopically enriched boron carbide (10B4C), and blends thereof.
    Type: Grant
    Filed: June 29, 2020
    Date of Patent: December 27, 2022
    Assignee: UT-Battelle, LLC
    Inventors: David C. Anderson, Amelia M. Elliott, Bianca Haberl, Garrett E. Granroth
  • Patent number: 11404180
    Abstract: Collimators and other components for use in neutron scattering experiments or to provide neutron shielding in nuclear reactors or accelerator based neutron sources are produced by additive manufacturing from neutron absorbing material, such as boron carbide (B4C) or isotopically enriched boron carbide (10B).
    Type: Grant
    Filed: October 9, 2018
    Date of Patent: August 2, 2022
    Assignee: UT-Battelle, LLC
    Inventors: David C. Anderson, Anibal J. Ramirez-Cuesta, Matthew B. Stone, Amelia M. Elliott, Derek H. Siddel
  • Patent number: 11270366
    Abstract: A user interface is described that enables a user to select and visualize different configurations of building products, perform a visual comparison of different configurations, save views of visualizations of the configurations, and obtain building product literature of the materials in the configurations. In some embodiments, the user interface can identify contractors for a user and facilitate communication with the contractors.
    Type: Grant
    Filed: February 26, 2019
    Date of Patent: March 8, 2022
    Assignee: Oldcastle BuildingEnvelope, Inc.
    Inventors: William L. West, David C. Anderson, Mark T. Green, Joshua M. Weber, Nathan B. Creech
  • Publication number: 20200411203
    Abstract: Collimators and other components for use in neutron scattering experiments or to provide neutron shielding in nuclear reactors or accelerator based neutron sources are produced by additive manufacturing from multiple different types of material, such as boron carbide (B4C), steel, isotopically enriched boron carbide (10B4C), and blends thereof.
    Type: Application
    Filed: June 29, 2020
    Publication date: December 31, 2020
    Inventors: David C. Anderson, Amelia M. Elliott, Bianca Haberl, Garrett E. Granroth
  • Publication number: 20200269318
    Abstract: A method for additive manufacturing of a composite object containing a bonded network of boron carbide particles and aluminum occupying spaces between boron carbide particles, the method comprising: (i) producing a porous preform constructed of boron carbide by an additive manufacturing process in which particles of boron carbide are bonded together; and (ii) infiltrating molten aluminum, at a temperature of 1000-1400° C., into pores of said porous preform to produce said composite object constructed of boron carbide particles within an aluminum matrix, wherein the boron carbide is present in the composite object in an amount of 30-70 wt. %. The resulting composite material is also herein described.
    Type: Application
    Filed: February 25, 2020
    Publication date: August 27, 2020
    Inventors: Corson L. Cramer, James O. Kiggans, JR., Amelia M. Elliott, David C. Anderson
  • Publication number: 20190266653
    Abstract: A user interface is described that enables a user to select and visualize different configurations of building products, perform a visual comparison of different configurations, save views of visualizations of the configurations, and obtain building product literature of the materials in the configurations. In some embodiments, the user interface can identify contractors for a user and facilitate communication with the contractors.
    Type: Application
    Filed: February 26, 2019
    Publication date: August 29, 2019
    Inventors: William L. West, David C. Anderson, Mark T. Green, Joshua M. Weber, Nathan B. Creech
  • Publication number: 20190108923
    Abstract: Collimators and other components for use in neutron scattering experiments or to provide neutron shielding in nuclear reactors or accelerator based neutron sources are produced by additive manufacturing from neutron absorbing material, such as boron carbide (B4C) or isotopically enriched boron carbide (10B).
    Type: Application
    Filed: October 9, 2018
    Publication date: April 11, 2019
    Inventors: David C. Anderson, Anibal J. Ramirez-Cuesta, Matthew B. Stone, Amelia M. Elliott, Derek H. Siddel
  • Patent number: 7604951
    Abstract: The present provides compounds capable of modulating IL-4 receptor-mediated IgE production, as well as IL-4 induced processes associated therewith, methods and kits for identifying such compounds that utilize a retinoid X receptor as a surrogate analyte and methods of using the compounds in a variety of in vitro, in vitro and ex vivo contexts.
    Type: Grant
    Filed: December 8, 2006
    Date of Patent: October 20, 2009
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Todd M. Kinsella, Esteban Masuda, Mark K. Bennett, Justin E. Warner, David C. Anderson
  • Patent number: 7598050
    Abstract: The present provides compounds capable of modulating IL-4 receptor-mediated IgE production, as well as IL-4 induced processes associated therewith, methods and kits for identifying such compounds that utilize a chloride intracellular channel 1 (CLIC1) as a surrogate analyte and methods of using the compounds in a variety of in vitro, in vitro and ex vivo contexts.
    Type: Grant
    Filed: December 8, 2006
    Date of Patent: October 6, 2009
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Esteban Masuda, Todd M. Kinsella, Justin E. Warner, Taisei Kinoshita, Mark K. Bennett, David C. Anderson
  • Patent number: 7563585
    Abstract: The present provides compounds capable of modulating IL-4 receptor-mediated IgE production, as well as IL-4 induced processes associated therewith, methods and kits for identifying such compounds that utilize a thioredoxin-like 32 kDa protein (TXNL) as a surrogate analyte and methods of using the compounds in a variety of in vitro, in vitro and ex vivo contexts.
    Type: Grant
    Filed: December 8, 2006
    Date of Patent: July 21, 2009
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Esteban Masuda, Todd M. Kinsella, Justin E. Warner, Taisei Kinoshita, Mark K. Bennett, David C. Anderson
  • Patent number: 7425418
    Abstract: The present provides compounds capable of modulating IL-4 receptor-mediated IgE production, as well as IL-4 induced processes associated therewith, methods and kits for identifying such compounds that utilize a retinoid X receptor as a surrogate analyte and methods of using the compounds in a variety of in vitro, in vitro and ex vivo contexts.
    Type: Grant
    Filed: March 15, 2002
    Date of Patent: September 16, 2008
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Todd M. Kinsella, Esteban Masuda, Mark K. Bennett, Justin E. Warner, David C. Anderson
  • Patent number: 7422867
    Abstract: The present provides compounds capable of modulating IL-4 receptor-mediated IgE production, as well as IL-4 induced processes associated therewith, methods and kits for identifying such compounds that utilize a CLLD8 protein as a surrogate analyte and methods of using the compounds in a variety of in vitro, in vitro and ex vivo contexts.
    Type: Grant
    Filed: April 4, 2007
    Date of Patent: September 9, 2008
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Esteban Masuda, Todd M. Kinsella, Justin E. Warner, Taisei Kinoshita, Mark K. Bennett, David C. Anderson
  • Patent number: 7378251
    Abstract: The present provides compounds capable of modulating IL-4 receptor-mediated IgE production, as well as IL-4 induced processes associated therewith, methods and kits for identifying such compounds that utilize a thioredoxin-like 32 kDa protein (TXNL) as a surrogate analyte and methods of using the compounds in a variety of in vitro, in vitro and ex vivo contexts.
    Type: Grant
    Filed: July 16, 2002
    Date of Patent: May 27, 2008
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Esteban Masuda, Todd M. Kinsella, Justin E. Warner, Taisei Kinoshita, Mark K. Bennett, David C. Anderson
  • Patent number: 7374894
    Abstract: The present provides compounds capable of modulating IL-4 receptor-mediated IgE production, as well as IL 4 induced processes associated therewith, methods and kits for identifying such compounds that utilize a chloride intracellular channel 1 (CLIC1) as a surrogate analyte and methods of using the compounds in a variety of in vitro, in vivo and ex vivo contexts.
    Type: Grant
    Filed: July 16, 2002
    Date of Patent: May 20, 2008
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Esteban Masuda, Todd M. Kinsella, Justin E. Warner, Taisei Kinoshita, Mark K. Bennett, David C. Anderson
  • Publication number: 20080108066
    Abstract: The present provides compounds capable of modulating IL-4 receptor-mediated IgE production, as well as IL-4 induced processes associated therewith, methods and kits for identifying such compounds that utilize a CLLD8 protein as a surrogate analyte and methods of using the compounds in a variety of in vitro, in vitro and ex vivo contexts.
    Type: Application
    Filed: April 4, 2007
    Publication date: May 8, 2008
    Inventors: Esteban Maduda, Todd M. Kinsella, Justin E. Warner, Taisei Kinoshita, Mark K. Bennett, David C. Anderson
  • Patent number: 7241581
    Abstract: The present provides compounds capable of modulating IL-4 receptor-mediated IgE production, as well as IL-4 induced processes associated therewith, methods and kits for identifying such compounds that utilize a c-Myc protein as a surrogate analyte and methods of using the compounds in a variety of in vitro, in vitro and ex vivo contexts.
    Type: Grant
    Filed: August 16, 2002
    Date of Patent: July 10, 2007
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Esteban Masuda, Todd M. Kinsella, Justin E. Warner, Taisei Kinoshita, Mark K. Bennett, David C. Anderson
  • Patent number: 7208289
    Abstract: The present provides compounds capable of modulating IL-4 receptor-mediated IgE production, as well as IL-4 induced processes associated therewith, methods and kits for identifying such compounds that utilize a CLLD8 protein as a surrogate analyte and methods of using the compounds in a variety of in vitro, in vitro and ex vivo contexts.
    Type: Grant
    Filed: December 30, 2004
    Date of Patent: April 24, 2007
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Esteban Masuda, Todd M. Kinsella, Justin E. Warner, Taisei Kinoshita, Mark K. Bennett, David C. Anderson